Articles From: UPDATE: European stocks slip as Ukraine-Russia tensions heat up to Fiat-Chrysler sees U.S. listing on Oct. 13


2014/9/1
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- European markets turned lower after a Russia's foreign minister said Moscow will defend the economy if it comes up against another round of sanctions related to the conflict in Ukraine.
Sign-up for UPDATE: European stocks slip as Ukraine-Russia tensions heat up investment picks
2014/9/1
By Chuck Jaffe, MarketWatch Most people who own "alternative mutual funds" can't accurately describe what they've got in their portfolio.
Sign-up for UPDATE: Is your 'alternative' fund a ticking time bomb? investment picks
2014/9/1
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- Here are some of the stocks that made notable moves in European trade Monday.
Sign-up for UPDATE: Novartis climbs, Iliad drops: European movers investment picks
2014/9/1
By Victor Reklaitis, MarketWatch Passive investing is now the mainstream approach, if you look at where dollars have flowed in the last 12 months.
Sign-up for UPDATE: Passive investing will keep gaining ground: Vanguard expert investment picks
2014/9/1
By Carla Mozee, MarketWatch LONDON (MarketWatch)--Tesco PLC shares were among the hardest hit in London trade on Monday, weighing on the FTSE 100 index, following a report that a major shareholder cut his stake in the supermarket chain.
Sign-up for UPDATE: Tesco shares extend losses, weigh on FTSE 100 investment picks
2014/9/1
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- Tesco PLC and HSBC PLC shares were among the hardest hit in London trade on Monday, weighing on the FTSE 100 index, after major shareholders cut their stakes in each company.
Sign-up for UPDATE: Tesco, HSBC shares weigh on FTSE 100 investment picks
2014/9/1
By Quentin Fottrell, MarketWatch Airlines get a bad rap from customers over delayed flights, high prices and baggage fees.
Sign-up for UPDATE: The worst thing about flying? These people investment picks
2014/9/1
By Catey Hill, MarketWatch Labor Day has become one of those shopping holidays when retailers advertise big sales to get people into stores, but shopping this weekend is not without its overpriced perils.
Sign-up for UPDATE: What not to buy over Labor Day weekend investment picks
By Wallace Witkowski, MarketWatch SAN FRANCISCO (MarketWatch) -- September has recently started shedding its reputation as one of the worst stock market months of the year, but strategists note the psychological pressure of big round numbers in the S&P 500 Index and the looming end of Federal Reserve asset purchases may serve to reinforce the month's stereotype.
Sign-up for UPDATE: Why September may slow further S&P records investment picks
2014/8/31
By Jeannette Neumann MADRID -- Caixabank SA has agreed to buy Barclays PLC's retail banking division in Spain as the British bank scales back its presence in less-profitable markets.
Sign-up for Caixabank to buy Barclays retail banking in Spain investment picks
St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced results from a large-scale, clinical study concluding that the St.
Sign-up for Large-scale Study Confirms Growing Body of Clinical Evidence for the St. Jude Medical Quadripolar System investment picks
By Wallace Witkowski, MarketWatch SAN FRANCISCO (MarketWatch)--Nike Inc. is reportedly matching an up-to-$285-million endorsement deal from Under Armour Inc. for Oklahoma City Thunder forward Kevin Durant that would keep the NBA star part of Team Swoosh for years to come.
Sign-up for Nike matches UA offer, to keep NBA star: report investment picks
2014/08/31
David Iben kept a low profile when he left Nuveen Tradewinds, but now the contrarian is back to running a new global all-cap strategy.
Sign-up for Noted Manager Stays Off the Beaten Path With New Global Fund investment picks
Symposium Builds on Philips' Support for SAVE Study Examining Impact of Obstructive Sleep Apnea Treatment on Cardiovascular Disease ANDOVER, Mass.
Sign-up for Philips Furthers Dialogue and Research on Cardiovascular Disease and Sleep Apnea at ESC Congress 2014 investment picks
Alirocumab, an investigational treatment for hypercholesterolemia, showed a 62 percent reduction in LDL-C compared to placebo at 24 weeks on top of maximally-tolerated lipid-lowering therapy in the ODYSSEY LONG TERM trial TARRYTOWN, New York and PARIS , Aug.
Sign-up for Regeneron and Sanofi Announce Presentation of Detailed Positive Results from Four Pivotal Alirocumab Trials at ESC Congress 2014 investment picks
-Only Rentrak Provides the Official Global Movie Results- LOS ANGELES , Aug.
Sign-up for Rentrak Announces Official Worldwide Box Office Results for Weekend of August 31, 2014 investment picks
2014/8/31
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0964920003&sourceType=1 http://www.ccnmatthews.com/logos/20051006-BMO170.jpg http://www.ccnmatthews.com/logos/20051024-bmo_bank_logo.gif TORONTO, ONTARIO --
Sign-up for REPEAT-Annual BMO Labour Day Survey: How Are Canadian Businesses Retaining Talented Employees? investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0965581001&sourceType=1 http://www.ccnmatthews.com/logos/20100511-GOBI%20LARGE.gif HONG KONG, CHINA --
Sign-up for Turquoise Hill Agrees to Limited Deferral of Repayment of All Amounts Due by SouthGobi Under the Shareholder Loan Facility investment picks
By Wallace Witkowski, MarketWatch SAN FRANCISCO (MarketWatch)--Nike Inc. is reportedly matching an up-to-$285-million endorsement deal from Under Armour Inc. for Oklahoma City Thunder forward Kevin Durant that would keep the NBA star part of Team Swoosh for years to come.
Sign-up for UPDATE: Nike matches UA offer, to keep NBA star: report investment picks
2014/8/31
Avago Technologies Ltd.
Sign-up for 10 best and worst S&P 500 stocks of 2014 -4- investment picks
2014/8/30
Alibaba Group is set to kick off its initial-public-offering process during the week of Sept.
Sign-up for Alibaba moving toward IPO by mid-September: report investment picks
Phase II feasibility trial provides first randomized sham-controlled data using vagus nerve stimulation to treat heart failure MARLBOROUGH, Mass.
Sign-up for Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1141102&ProfileId=051205&sourceType=1 HAMBURG, NY --
Sign-up for dressbarn of Hamburg Celebrates Grand Reopening investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G020835-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/8/29/11G020835/mw18sbc71j11nkikt31oqs1bfcl832-1291963499582.jpg NEW YORK, NY--(Marketwired - August 30, 2014) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in EZCORP, Inc. ("EZCORP" or the "Company") (NASDAQ: EZPW) of the October 21, 2014 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against EZCORP and certain executives.
Sign-up for Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in EZCORP, Inc. (EZPW) to Contact the Firm investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G020829-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/8/29/11G020829/mw18sbc71j11nkikt31oqs1bfcl832-1291963499582.jpg NEW YORK, NY--(Marketwired - August 30, 2014) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Lannett Company, Inc. ("Lannett" or the "Company") (NYSE: LCI) of the October 27, 2014 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against Lannett and certain executives.
Sign-up for Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Lannett Company, Inc. (LCI) to Contact the Firm investment picks
2014/8/30
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G020836-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/8/29/11G020836/mw18sbc71j11nkikt31oqs1bfcl832-1291963499582.jpg NEW YORK, NY--(Marketwired - August 30, 2014) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Santander Consumer USA Holdings Inc. ("Santander" or the "Company") (NYSE: SC) of the October 27, 2014 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against Santander, certain executives and directors, and underwriters of the Company's January 23, 2014 initial public offering (the "IPO"). A complaint has been filed in the Southern District of New York on behalf of all persons who purchased or otherwise acquired Santander securities pursuant and/or traceable to the Company's Registration Statement and Prospectus (collectively, the
Sign-up for Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Santander Consumer USA Holdings Inc. (SC) to Contact the Firm investment picks
2014/8/30
Fiat-Chrysler plans to list shares in the recently-merged automaker in New York on Oct.
Sign-up for Fiat-Chrysler sees U.S. listing on Oct. 13 investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: UPDATE: European stocks slip as Ukraine-Russia tensions heat up to Fiat-Chrysler sees U.S. listing on Oct. 13
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent